TREATMENT OF TYPE 2 DIABETES

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20130131065A1
SERIAL NO

13703138

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to triazine derivatives of Formula I for their use in the treatment of Type 2 diabetes, and to compositions comprising said triazine derivatives.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
POXELIMMEUBLE LE SUNWAY 259/261 AVENUE JEAN JAURÈS LYON 69007

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bolze, Sébastien Massieux, FR 13 7
Cravo, Daniel Montesson, FR 33 169
Fouqueray, Pascale Sins, CH 9 5
Hallakou-Bozec, Sophie Montrouge, FR 19 64

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation